Ethnicity is a factor to be considered before dose planning in ovarian cancer patients to be treated with Topotecan(Oncology 1)
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-02-01
著者
-
Tam Kf
Department Of Obstetrics And Gynaecology The University Of Hong Kong
-
Chan YM
Department of Obstetrics and Gynaecology, The University of Hong Kong
-
Ng TY
Department of Obstetrics and Gynaecology, The University of Hong Kong
-
Wong LC
Department of Obstetrics and Gynaecology, The University of Hong Kong
-
Ngan HYS
Department of Obstetrics and Gynaecology, The University of Hong Kong
-
Ng Ty
Department Of Obstetrics And Gynaecology The University Of Hong Kong
-
Chan Ym
Department Of Obstetrics And Gynaecology The University Of Hong Kong
-
Wong Lc
Department Of Obstetrics And Gynaecology The University Of Hong Kong
-
Ngan Hys
Department Of Obstetrics And Gynaecology The University Of Hong Kong